Dongguang, China

Jielian Lu

This inventor holds 1 USPTO granted patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jielian Lu. Retrieved from https://idiyas.com/inventor/jielian-lu-otb0hzn7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jielian Lu - Innovator in Antibody Development

Introduction

Jielian Lu is a prominent inventor based in Dongguang, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. His work is characterized by a commitment to advancing medical science and improving therapeutic options.

Latest Patents

Jielian Lu holds a patent for "Humanized Anti-TRKA Antibodies and Uses Thereof." This patent represents a crucial advancement in the treatment of various conditions, showcasing his expertise in antibody engineering and therapeutic applications. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Lu is currently employed at Sunshine Lake Pharma Co., Ltd., where he continues to push the boundaries of pharmaceutical research and development. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking projects.

Collaborations

Throughout his career, Jielian Lu has worked alongside notable colleagues, including Zhiheng Ren and Junji Dong. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective areas of expertise.

Conclusion

Jielian Lu is a dedicated inventor whose work in antibody development is making a meaningful impact in the field of biotechnology. His innovative spirit and collaborative efforts continue to drive progress in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…